WIP Psychiatry & Ketamine/TMS Center
4325 49th Street Northwest, Suite 200, Washington
4.9(236 Google reviews)
United States
5 listed treatment centers serving Washington and the surrounding area.
4325 49th Street Northwest, Suite 200, Washington
4.9(236 Google reviews)
8000 Towers Crescent Drive, Suite a150, Vienna
4.9(76 Google reviews)
1400 16th Street Northwest, Suite 101, Washington
4.9(40 Google reviews)
5480 Wisconsin Avenue, 223, Chevy Chase
4.0(4 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Washington.
6 miles away · Bethesda
The cost of SPRAVATO® treatment in Washington depends on your insurance benefits, the treatment setting, and the services billed. Both the medication and the observed treatment and monitoring visit may generate charges. Ask for an explanation of each component rather than assuming a medication estimate covers the entire appointment.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you took, how long you took them, and how you responded. A treatment center can explain what documentation it needs from your current or previous prescribers. Authorization is not a guarantee that every charge will be paid.
Medicare may cover Spravato through Part B or Part D, depending on the plan and setting. District of Columbia Medicaid coverage also depends on the applicable plan and its requirements. Confirm benefits directly with your insurer and ask whether the center can bill your coverage; a directory listing does not establish participation or coverage.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility rules and covered expenses vary, so ask about current terms without assuming assistance will apply.
Before starting, ask the center and insurer:
This city page currently has no listed SPRAVATO® treatment center in Washington. Nearby listed cities include Chevy Chase and Vienna. Those listings do not confirm REMS certification, so contact a prospective center to verify certification, current treatment availability, and whether it can evaluate you before arranging travel.
Spravato is administered only in a REMS-certified healthcare setting. You use the nasal spray yourself under a healthcare provider’s direct observation; it is not a prescription you take home. Monitoring continues for at least two hours after each dose, and the full appointment may take longer because of preparation and assessment before discharge.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule appropriate for your situation; do not assume visits will decrease on a fixed personal timeline.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and discharge requirements before relying on a hired ride, and have a backup if your planned driver cancels.
When planning treatment, consider:
This city page currently has no listed SPRAVATO® center in Washington. Listings are available in Chevy Chase and Vienna, but their REMS certification is not confirmed in the directory information. Contact centers directly to confirm certification, whether they are accepting patients, and what an evaluation involves. A listing alone does not establish that a center is appropriate for your needs.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. It is not approved for children. A clinician must review your symptoms, treatment history, medical conditions, and medicines to determine whether it is appropriate.
Coverage depends on your plan and treatment setting. Prior authorization and documentation of previous antidepressant trials are common requirements. Medicare and District of Columbia Medicaid may cover treatment under applicable plan rules, but coverage and center participation need confirmation. Ask about both the medication and monitoring charges, your potential share of costs, and whether authorization must be renewed during treatment.
You self-administer the nasal spray under direct observation in a REMS-certified healthcare setting. Staff monitor you for at least two hours after the dose, including checks for sedation, dissociation, breathing problems, and blood pressure increases. The full appointment may take longer. You cannot take the medication home, and you need someone else to drive you home afterward.
Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history and all medicines with the prescriber, and follow the monitoring and next-day driving restrictions.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Do not wait for a treatment appointment if you need urgent help. In a crisis, call or text 988. If you are in immediate danger or have a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.